Your browser doesn't support javascript.
loading
COVID-19 therapeutics for the pregnant patient.
Triebwasser, Jourdan E; Davies, Jill K; Nestani, Ajleeta.
Affiliation
  • Triebwasser JE; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Michigan, United States. Electronic address: jtriebwa@med.umich.edu.
  • Davies JK; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Michigan, United States.
  • Nestani A; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Michigan, United States.
Semin Perinatol ; 48(4): 151920, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38866675
ABSTRACT
SARS-CoV-2 infection can cause severe disease among pregnant persons. Pregnant persons were not included in initial studies of therapeutics for COVID-19, but cumulative experience demonstrates that most are safe for pregnant persons and the fetus, and effective for prevention or treatment of severe COVID-19.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Pregnancy Complications, Infectious / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Limits: Female / Humans / Pregnancy Language: En Journal: Semin Perinatol Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Pregnancy Complications, Infectious / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Limits: Female / Humans / Pregnancy Language: En Journal: Semin Perinatol Year: 2024 Document type: Article